Arrowhead's ARO-INHBE obesity trial remains active, not recruiting, with 190 enrolledOct 30Trial updateARO-INHBEArrowhead Pharmaceuticals
Arrowhead's two Phase 3 plozasiran SHTG trials both show completed status this weekOct 9Weekly roundup, 4 itemsARO-INHBEArrowhead PharmaceuticalsUpdated
Sign inSign in